Ligand Pharmaceuticals Incorporated (LGND)
Ligand Pharmaceuticals Incorporated (LGND)
$113.55 USD
Updated Jul 19 12:00am
Add LGND to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
LGND News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
Best & Worst Performing Stock Industries for July 19, 2019
Best & Worst Performing Small Cap Stocks for July 19, 2019
Best & Worst Performing Mid Cap Stocks for July 19, 2019
Best & Worst Performing Mega Cap Stocks for July 19, 2019
Best & Worst Performing Large Cap Stocks for July 19, 2019
View All Top StoriesLigand Pharmaceuticals Incorporated (LGND) Company Bio
Ligand Pharmaceuticals develops therapies that address the unmet medical needs of patients for a range of diseases, including hepatitis, multiple myeloma, muscle wasting, Alzheimers disease, dyslipidemia, diabetes, anemia, epilepsy, focal segmental glomerulosclerosis, and osteoporosis. The company was founded in 1987 and is based in La Jolla, California.
LGND Stock Chart More Charts
LGND Price/Volume Stats
| Current price | $113.55 |
| Prev. close | $114.88 |
| Day low | $113.53 |
| Day high | $116.50 |
| 50-day MA | $113.54 |
| 200-day MA | $134.81 |
| 52-week high | $278.62 |
| 52-week low | $98.56 |
| Volume | 207,600 |
| Avg. volume | 516,754 |
| Dividend yield | N/A |
| Market Cap | 2.23B |
LGND Returns
| 1-mo | 1.48% |
| 3-mo | -9.77% |
| 6-mo | 0.57% |
| 1-year | -51.03% |
| 3-year | -13.95% |
| 5-year | 131.07% |
| YTD | -16.32% |
| 2018 | -0.90% |
| 2017 | 34.76% |
| 2016 | -6.28% |
| 2015 | 103.76% |
| 2014 | 1.16% |
Loading social stream, please wait...